| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $339K | — | -4.5% |
| Cost of Revenue | $66K | — | -38.2% |
| Gross Profit | $272K | — | +10.2% |
| R&D Expense | $58K | — | — |
| SG&A Expense | $1.3M | — | +164.2% |
| Pre-tax Income | -$1.3M | — | -355.2% |
| Net Income | -$1.3M | — | -355.2% |
| EPS (Basic) | -$0.11 | — | -266.7% |
| EPS (Diluted) | -$0.11 | — | -266.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $263K | +65.0% | — |
| Current Assets | $2.2M | -55.0% | — |
| Total Assets | $4.0M | -20.4% | — |
| Current Liabilities | $637K | +22.7% | — |
| Total Liabilities | $637K | +22.7% | — |
| Stockholders' Equity | $3.4M | -25.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.0M | — | -290.7% |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | -$1.6M | — | — |
| Financing Cash Flow | $94K | — | +0.0% |
| Free Cash Flow | -$2.2M | — | — |